⬇️ 下载 PDF
红蓝生物

🧬 乌纳基单抗ELISA检测试剂盒

Vunakizumab ELISA Kit

货号: RB9T37017358
💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
🏷️ 产品编码
RB9T37017358
🧬 中文名称
乌纳基单抗ELISA检测试剂盒
📝 英文名称
Vunakizumab ELISA Kit
🔬 应用
ELISA
🔢 登录号
Q16552
🔹 靶标
乌纳基单抗酶联免疫检测试剂盒
🔹 检测方法
Colorimetric
🔹 灵敏度
0.156 μg/ml
🔹 检测范围
0.31-5 μg/mL
🔹 回收率
80-120%
🔹 样本类型
Plasma, Serum
🔹 检测类型
Quantitative
🔹 背景信息
Vunakizumab is a recombinant humanized IgGκ monoclonal antibody binds to and neutralises the proinflammatory cytokine interleukin-17A (IL-17A). It was discovered and developed by Jiangsu Hengrui Medicine (China) with the developmental name SHR-1314, for the treatment of autoimmune diseases such as psoriasis, psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis. Atridia Pty. Ltd., which is now a part of Jiangsu Hengrui Medicine, start a phase-I clinical trial in psoriasis (in volunteers) in Australia in August 2016. Atridia completed the phase-I trial in July 2017. A phase-I/II study, which is started from December 2017, is ongoing to assess the safety, tolerability, and pharmacokinetics of SHR-1314 with expanded dose finding in subjects with moderate-to-severe plaque psoriasis.
🏷️ 别名
SHR-1314, 1792181-33-9
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.